IRMD - IRadimed Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
25.60
-0.69 (-2.62%)
As of 1:26PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close25.56
Open26.35
Bid25.46 x 800
Ask25.59 x 1000
Day's Range25.32 - 26.74
52 Week Range13.75 - 38.78
Volume44,816
Avg. Volume72,631
Market Cap281.526M
Beta (3Y Monthly)2.05
PE Ratio (TTM)49.23
EPS (TTM)0.52
Earnings DateOct 26, 2017 - Oct 30, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.00
Trade prices are not sourced from all markets
  • Who Has Been Selling IRadimed Corporation (NASDAQ:IRMD) Shares?
    Simply Wall St.9 days ago

    Who Has Been Selling IRadimed Corporation (NASDAQ:IRMD) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share pricesRead More...

  • GuruFocus.com11 days ago

    iRadimed Corp (IRMD) Files 10-K for the Fiscal Year Ended on December 31, 2018

    iRadimed Corp (NASDAQ:IRMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.

  • Is IRadimed Corporation (NASDAQ:IRMD) A Volatile Stock?
    Simply Wall St.27 days ago

    Is IRadimed Corporation (NASDAQ:IRMD) A Volatile Stock?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Anyone researching IRadimed Corporation (NASDAQ:IRMD) might want to consider theRead More...

  • GuruFocus.comlast month

    Outperformance and Thinking Differently, Part 2: Allocating Time

    There is an old story about Hubert Lyautey, a French army marshal, elder statesman and a former administrator of the French colony of Morocco. In the story, Lyautey goes to his gardener one day and asks him to plant a certain type of tree in the back garden of his chateau. "In that case," Lyautey replied, "there is no time to lose.

  • IRADIMED (IRMD) Q4 Earnings Surpass Estimates, Margins Up
    Zackslast month

    IRADIMED (IRMD) Q4 Earnings Surpass Estimates, Margins Up

    IRADIMED (IRMD) reports growth across all operating segments and geographies

  • Thomson Reuters StreetEventslast month

    Edited Transcript of IRMD earnings conference call or presentation 6-Feb-19 4:00pm GMT

    Q4 2018 IRadimed Corp Earnings Call

  • iRadimed Corp (IRMD) Q4 2018 Earnings Conference Call Transcript
    Motley Foollast month

    iRadimed Corp (IRMD) Q4 2018 Earnings Conference Call Transcript

    IRMD earnings call for the period ending December 31, 2018.

  • IRadimed (IRMD) Q4 Earnings and Revenues Beat Estimates
    Zackslast month

    IRadimed (IRMD) Q4 Earnings and Revenues Beat Estimates

    iRadimed (IRMD) delivered earnings and revenue surprises of 23.08% and 1.82%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    IRadimed: 4Q Earnings Snapshot

    On a per-share basis, the Winter Springs, Florida-based company said it had net income of 14 cents. Earnings, adjusted for stock option expense, were 16 cents per share. The maker of IV devices that can ...

  • GlobeNewswirelast month

    IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results

    Reports fourth quarter 2018 revenue of $8.3 millionReports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16Announces 2019 full year and first.

  • IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?
    Zacks2 months ago

    IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?

    IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Should We Be Delighted With IRadimed Corporation’s (NASDAQ:IRMD) ROE Of 12%?
    Simply Wall St.2 months ago

    Should We Be Delighted With IRadimed Corporation’s (NASDAQ:IRMD) ROE Of 12%?

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...

  • GlobeNewswire2 months ago

    IRADIMED CORPORATION to Hold 2018 Fourth Quarter Financial Results Conference Call on February 6th

    WINTER SPRINGS, Fla., Jan. 22, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the.

  • GlobeNewswire2 months ago

    IRADIMED CORPORATION Expects Minor Impact to 2019 Revenue After Temporarily Suspending Shipments of MRI Compatible Patient Vital Signs Monitoring Systems in European Markets

    IRADIMED CORPORATION (IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices today announced that it temporarily suspended sales of its 3880 MRI compatible patient vital signs monitoring systems in European Commission (“EC”) markets due to the expiration of its CE Mark on January 17, 2019. Maintaining Certification and use of the CE Mark requires manufacturers to routinely undergo periodic re-certification, which typically involves the re-review of a product technical file.

  • InvestorPlace2 months ago

    10 High-Growth Stocks for the Return of the Bull

    The market is off to its best start since 1987. That seems a double-edged sword, given what happened to the market that October. But aside from that swoon, it was a good year. However, this isn't 1987. The massive selloff we saw begin just before Q4 in select sectors spread through the broad market. And December was particularly brutal. But now that it's over, prices have come down to more reasonable levels, getting buyers interested in getting back into stocks, even if Q4 and Q1 earnings don't set the world on fire. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Just yesterday, the markets took off on slight hints from the administration that there may be some lifting of tariffs in the China-U.S. trade war. * 7 Retail Stocks to Buy for the Rise of Menswear Now, I wouldn't hang my hat on those soft rumors, especially from politicians that have tied their fate to market performance. But the fact is, the economy is coming back, and that's worth your attention. Following are 10 high-growth stocks for the return of the bull, all of which are A-rated stocks in my Portfolio Grader. ### CyberArk Software (CYBR) CyberArk Software (NASDAQ:CYBR) is an Israeli firm that specializes in access security, particularly for highly regulated and security-focused industries like healthcare, financial services, energy and retail markets. It focuses on making sure what's going on in the front office and the back office don't get muddled, and keeping hackers and malware at bay. As you have seen from various hacks in the past year, this is a growing expense for corporate victims and opens them up to costly and time-consuming lawsuits. Up 89% in the past 12 months, CYBR is on a roll. And coming in with just a $2.9 billion market cap, it has plenty of growth ahead of it, especially in these sectors. ### iRadimed (IRMD) iRadimed (NASDAQ:IRMD) has a very interesting and very profitable niche market. It specializes in making, selling and maintaining equipment and products that are compatible with magnetic resonance imaging (MRI) equipment. This may not seem like a big deal, but MRIs are powered by massive magnets, so there can't be any metal in the room (or in a person's body sometimes). This becomes a challenge when you need to have monitors or testing equipment with the patient as they're undergoing evaluation. Also, MRI diagnostics are becoming a helpful (and cost effective) way to move patients along the proper line of care. Insurance companies like that, as to do hospitals. * 7 Stocks to Buy as the Dollar Weakens Up 73% in the past 12 months, it only sports a market cap around $290 million, so don't chase it too far. ### Pro-Dex (PDEX) Pro-Dex (NASDAQ:PDEX) is a small company that engineers and manufactures high-precision tools across a number of different industries. For example, it makes rotary surgical and dental instruments, but it also makes products for other industries where tolerances are tight and reliability is crucial. But the lion's share of its business is as a medical device manufacturer -- and that is good enough, since that sector is in high demand both in the U.S. and in Asia, especially China, where they are focused on beefing up their healthcare delivery and quality. At a market cap just $56 million, it's not a major player, but it does have a strong niche that is growing. PDEX stock is up almost 90% in the past 12 months yet only trades at a trailing price-to-earnings ratio of 25. ### Brasil-Agro Companhia Brasileira de Propriedades Agricolas (LND) Brasil-Agro Companhia Brasileira de Propriedades Agricolas (NYSE:LND) may not roll off your tongue, but is in the business of buying and developing land for cattle, sugarcane and grains. Brazil just got a new president who is being compared to South America's version of Donald Trump. And he's already opening up indigenous land and rainforest to commercial operations. This is very good news for LND. * 10 Growth Stocks With the Future Written All Over Them The stock is only up about 5.5% in the past 12 months, but Brazil was in pretty tough shape. Now that a new path to growth is underway, LND has a lot of potential. And it's a good value here. ### UFP Technologies (UFPT) UFP Technologies (NASDAQ:UFPT) specializes in creating custom packaging, component and product solutions for OEMs in key strategic sectors like medical, automotive, aerospace, electronics and consumer. All these are growth areas and UFPT is a U.S. supplier, so it has an upper hand over the challenges of dealing with Chinese competitors. What's more, it specializes in high-end products and packaging, so it has a unique niche. And security-focused companies also like to work with U.S.-based firms. Finally, many of these sectors are fairly price elastic, so they will pay more for what they specifically want. Up 8% in the past 12 months, a revitalized economy will really boost its top and bottom lines. ### QuinStreet (QNST) QuinStreet (NASDAQ:QNST) delivers "performance marketing products and technologies" to its customers. Basically, what that means is, they help businesses find customers on the internet. Through various strategies, QNST helps companies define, locate and acquire new business opportunities using their various tools, analytics and strategies. This is a new but vibrant niche and QNST is growing like kudzu. The stock is up over 100% in the past 12 months and it's closing in on a $1 billion market cap. * 8 Dividend Stocks With Growth on the Horizon As the digital world becomes more omnipresent and complex, companies that help small and medium-sized businesses navigate it will be in greater demand. ### Jernigan Capital (JCAP) Jernigan Capital (NYSE:JCAP) is an interesting real estate investment trust (REIT). It specializes in developing and managing storage properties. Usually REITs will focus on retail or tech or healthcare, but few solely focus their business on the self-storage sector. But it's a good idea. There are few sectors that are growing like self-storage, and that growth will continue as the economy continues to expand and people become more mobile, looking for better opportunities wherever they may pop up. As a REIT, JCAP distributes its net profits in the form of a dividend. So this stock is best bought for the long term, since scoring its 6.6% dividend is all part of the investment. Its 14% return over the past 12 months kicks its annual return to near 20%. ### Veeva Systems (VEEV) Veeva Systems (NYSE:VEEV) is an exciting company that is becoming a dominant player in an increasingly important niche -- cloud-based software solutions for the life sciences industry. Given the highly regulated and technical nature that life sciences companies deal with on a day to day basis, it makes perfect sense that the type of systems they need to manage testing, quality control, regulatory issues, marketing, etc need to be highly specialized. And that's precisely what VEEV does. * 10 A-Rated Stocks the Smart Money Is Piling Into The fact is, this sector is only going to grow in coming years. And VEEV will be a major beneficiary. Up 86% in the past year, it has plenty of legs left. ### Ritchie Bros Auctioneers (RBA) Ritchie Bros Auctioneers (NYSE:RBA) is certainly a unique company that has been building its brand since 1958. It buys and sells industrial equipment. Its tag line is, "Where the world buys and sells industrial equipment." That gives you an idea of how focused its business is. But it does one thing beyond selling construction, agriculture, drilling and mining equipment and more. It finances it. And in this phase of recovery, both the sales and the financing are a great place to be. This won't be a rocket ship to the moon, but it will see some solid, long-term growth as the world gets back on its feet and interest rates continue to rise. ### Freidman Industries (FRD) Freidman Industries (NYSEAMERICAN:FRD) has been in the steel industry since 1965. It has two divisions -- Coil, which produces hot rolled steel and coils; and Tubular, which produces steel pipes. All these products supply core industries that will continue to demand product as the economy revives -- rail, containers, pipelines, steel buildings, and oil and gas exploration. And because it's a U.S. company, there's no threat of getting hit with surprise tariffs or production delays due to trade issues. * 7 Retail Stocks to Buy for the Rise of Menswear FRD has $54 million market cap, so it's a small player that has solid long-term customers. And as its customers grow, so will it. Up 42% last year, the good times are just beginning. Louis Navellier is a renowned growth investor. He is the editor of four investing newsletters: Growth Investor, Breakthrough Stocks, Accelerated Profits and Platinum Growth. His most popular service, Growth Investor, has a track record of beating the market 3:1 over the last 14 years. He uses a combination of quantitative and fundamental analysis to identify market-beating stocks. Mr. Navellier has made his proven formula accessible to investors via his free, online stock rating tool, PortfolioGrader.com. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Companies Apple Should Consider Buying * 7 Beaten-Up Housing Stocks Due for a Bounce Back * Take Buffett's Advice: 5 Vanguard Funds to Buy Compare Brokers The post 10 High-Growth Stocks for the Return of the Bull appeared first on InvestorPlace.

  • Thoughts on 2018 Performance
    GuruFocus.com2 months ago

    Thoughts on 2018 Performance

    The following is an update on the 2018 performance of individual accounts I run along with the returns of the Hayashi Foundation - a not-for-profit fund based in Japan, of which I am currently chief investment officer. As many of you know, I left Dorfman Value Investments and opened my own investment firm - Nintai Investments LLC - on Oct. 1, 2018. The numbers in this report reflect a composite of fees from both Dorfman and Nintai.

  • What Is IRadimed Corporation’s (NASDAQ:IRMD) Share Price Doing?
    Simply Wall St.3 months ago

    What Is IRadimed Corporation’s (NASDAQ:IRMD) Share Price Doing?

    IRadimed Corporation (NASDAQ:IRMD), which is in the medical equipment business, and is based in United States, saw significant share price movement during recent months on the NasdaqCM, rising to highs Read More...

  • GlobeNewswire3 months ago

    IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor

    IRADIMED CORPORATION (IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced FDA 510(k) clearance of its 3883 MRI-compatible invasive blood pressure module for use with its 3880 MRI compatible patient vital signs monitoring system. “This newly cleared device represents a feature extension to the 3880 MRI-compatible patient monitoring system, which we launched in the U.S. just over a year ago. With the invasive blood pressure module, we now offer advanced monitoring capabilities to our customers,” said Roger Susi, President and Chief Executive Officer of the Company.

  • Don’t Sell IRadimed Corporation (NASDAQ:IRMD) Before You Read This
    Simply Wall St.4 months ago

    Don’t Sell IRadimed Corporation (NASDAQ:IRMD) Before You Read This

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll look at IRadimed Corporation’s (NASDAQ:IRMD) P/E ratio and reflect on Read More...

  • GlobeNewswire4 months ago

    New Research Coverage Highlights Beasley Broadcast Group, Resolute Energy, Hanger, Inspired Entertainment, Saratoga Investment, and iRadimed — Consolidated Revenues, Company Growth, and Expectations for 2018

    NEW YORK, Nov. 16, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of IRMD earnings conference call or presentation 30-Oct-18 3:00pm GMT

    Q3 2018 IRadimed Corp Earnings Call

  • Simply Wall St.5 months ago

    What Kind Of Shareholder Owns Most IRadimed Corporation (NASDAQ:IRMD) Stock?

    Every investor in IRadimed Corporation (NASDAQ:IRMD) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders owning Read More...

  • IRadimed (IRMD) Q3 Earnings and Revenues Beat Estimates
    Zacks5 months ago

    IRadimed (IRMD) Q3 Earnings and Revenues Beat Estimates

    iRadimed (IRMD) delivered earnings and revenue surprises of 40.00% and 2.52%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press5 months ago

    IRadimed: 3Q Earnings Snapshot

    The Winter Springs, Florida-based company said it had net income of 20 cents per share. Earnings, adjusted for pretax gains, came to 14 cents per share. The maker of IV devices that can be used in MRI ...